Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 15
2003 11
2004 10
2005 12
2006 16
2007 15
2008 26
2009 20
2010 25
2011 29
2012 31
2013 59
2014 44
2015 38
2016 43
2017 41
2018 35
2019 35
2020 55
2021 61
2022 55
2023 51
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

654 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Miller DS, et al. Among authors: matsumoto t. J Clin Oncol. 2020 Nov 20;38(33):3841-3850. doi: 10.1200/JCO.20.01076. Epub 2020 Sep 29. J Clin Oncol. 2020. PMID: 33078978 Free PMC article. Clinical Trial.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: matsumoto t. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Free PMC article. Clinical Trial.
Adverse Events of Abiraterone Acetate vs Enzalutamide.
Blas L, Shiota M, Tsukahara S, Nagakawa S, Matsumoto T, Eto M. Blas L, et al. Among authors: matsumoto t. Urol Pract. 2023 Jul;10(4):361-370. doi: 10.1097/UPJ.0000000000000404. Epub 2023 Apr 4. Urol Pract. 2023. PMID: 37103554
Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression.
Yamane T, Kanamori Y, Sawayama H, Yano H, Nita A, Ohta Y, Hinokuma H, Maeda A, Iwai A, Matsumoto T, Shimoda M, Niimura M, Usuki S, Yasuda-Yoshihara N, Niwa M, Baba Y, Ishimoto T, Komohara Y, Sawa T, Hirayama T, Baba H, Moroishi T. Yamane T, et al. Among authors: matsumoto t. JCI Insight. 2022 Nov 8;7(21):e156802. doi: 10.1172/jci.insight.156802. JCI Insight. 2022. PMID: 36136589 Free PMC article.
Androgen receptor mutations for precision medicine in prostate cancer.
Shiota M, Akamatsu S, Tsukahara S, Nagakawa S, Matsumoto T, Eto M. Shiota M, et al. Among authors: matsumoto t. Endocr Relat Cancer. 2022 Aug 17;29(10):R143-R155. doi: 10.1530/ERC-22-0140. Print 2022 Oct 1. Endocr Relat Cancer. 2022. PMID: 35900853 Review.
Takotsubo syndrome following MitraClip procedure.
Nomura T, Munehisa Y, Nakashima M, Matsumoto T. Nomura T, et al. Among authors: matsumoto t. Eur Heart J Case Rep. 2020 Nov 9;4(6):1-2. doi: 10.1093/ehjcr/ytaa384. eCollection 2020 Dec. Eur Heart J Case Rep. 2020. PMID: 33634224 Free PMC article. No abstract available.
654 results